Literature DB >> 3624946

Regulation of smooth muscle proliferation by heparin in vitro and in vivo.

A W Clowes, M M Clowes.   

Abstract

Smooth muscle cell proliferation is central to the development of atherosclerotic plaques, intimal thickening, and recurrent stenosis in arteries following surgical reconstruction. The factors that might limit this process remain poorly defined. Studies reported recently from several laboratories suggest that heparin administered in pharmacological doses can suppress proliferation of smooth muscle cells. Furthermore, heparin-like molecules are synthesized by vascular wall cells, inhibit smooth muscle growth in vitro, and might act to regulate smooth muscle growth within the arterial wall.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3624946

Source DB:  PubMed          Journal:  Int Angiol        ISSN: 0392-9590            Impact factor:   2.789


  4 in total

1.  Heparin inhibits phosphorylation and autonomous activity of Ca(2+)/calmodulin-dependent protein kinase II in vascular smooth muscle cells.

Authors:  Ketu Mishra-Gorur; Harold A Singer; John J Castellot
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

2.  Regulation of vascular smooth muscle proliferation by heparin: inhibition of cyclin-dependent kinase 2 activity by p27(kip1).

Authors:  Stephen Fasciano; Rekha C Patel; Indhira Handy; Chandrashekhar V Patel
Journal:  J Biol Chem       Date:  2005-02-24       Impact factor: 5.157

3.  The effect of pancreatopeptidase E (elastase) on anastomotic intimal thickness in two types of vascular prosthesis.

Authors:  F Akimoto
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

4.  The mechanisms of nadroparin-mediated inhibition of proliferation of two human lung cancer cell lines.

Authors:  Y Carmazzi; M Iorio; C Armani; S Cianchetti; F Raggi; T Neri; C Cordazzo; S Petrini; R Vanacore; F Bogazzi; P Paggiaro; A Celi
Journal:  Cell Prolif       Date:  2012-12       Impact factor: 6.831

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.